BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• GWave by HAGAR to Present at Renowned Global Diabetes Conference

  HAGAR will present data from two of its completed clinical studies at the upcoming 15th International Conference.

  April 7, 2022

   · 

  2 min read
• Genetown

  Vizgen Showcases Benefits of Spatial Genomics Platform in Understanding the Tumor Microenvironment at AACR 2022 Annual Meeting

  Vizgen today announced that it will be presenting a poster at the 2022 American Association for Cancer Research (AACR) Annual Meeting.

  April 7, 2022

   · 

  3 min read
• Business

  AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance

  AngioDynamics, Inc. today announced financial results for the third quarter of fiscal year 2022, which ended February 28, 2022.

  April 7, 2022

   · 

  18 min read
• Biotech Bay

  Viz.ai Raises $100 Million in Series D Funding, Led by Tiger Global and Insight Partners at $1.2 Billion Valuation

  Viz.ai , the leading AI-powered disease detection and care coordination platform, has raised a $100 million funding round at a $1.2 billion valuation.

  April 7, 2022

   · 

  7 min read
• Genetown

  Study Establishes Boston Cell Standards’ Calibrated IHC Technology for Companion Diagnostic Immunohistochemistry

  Boston Cell Standards today announced the publication of a study and accompanying editorial in the peer-reviewed journal Modern Pathology, evaluating its Calibrated IHC (cIHC) technology in ensuring accuracy for companion diagnostic testing.

  April 7, 2022

   · 

  3 min read
• Drug Development

  Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

  Aptinyx Inc. today announced results from a Phase 2b clinical study evaluating the effects of NYX-2925 in patients with painful diabetic peripheral neuropathy (DPN).

  April 7, 2022

   · 

  6 min read
• Deals

  Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer

  Andera Partners announced today that Pfizer Inc. has entered into a definitive agreement to acquire Andera Life Sciences’ portfolio company ReViral Ltd.

  April 7, 2022

   · 

  4 min read
• Business

  IAVI and Moderna Partner to Tackle Broad Global Health Priorities Using mRNA for Vaccines and Antibodies

  Moderna, Inc. today announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health threats.

  April 7, 2022

   · 

  7 min read
• Business

  VectivBio Reports Full Year 2021 Financial Results and Provides Business Update

  VectivBio Holding AG today reported financial results and provided a business update for the full year ended December 31, 2021.

  April 7, 2022

   · 

  12 min read
• Business

  Brendon Stiles, MD, Joins LUNGevity Scientific Advisory Board

  LUNGevity Foundation extends its welcome to the foundation’s newest Scientific Advisory Board member, Brendon Stiles, MD.

  April 7, 2022

   · 

  3 min read